Artios Pharma Limited: Valuation, Funding & Investors
A biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (DDR) in cancer. Artios is pioneering next-generation approaches in the DDR field through its comprehensive anti-cancer approach and the deep experience of its team of DDR drug developers.
Leadership & Board
- Current Number of Employees
- 129
- Current LinkedIn Followers
- 13,756
Latest Estimated Valuation
- Total Amount Raised
- $115M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $115M
- Latest Funding Round
- Series D
Employee Trend
Artios Pharma Limited had 129 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Artios Pharma Limited had 13,756 followers as of November 2, 2026. The number of followers increased by 11 (0.08%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 17, 2025 | Series D | $115.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Omega Funds | Series D |
| Schroders Capital | Series D |
| SV Health Investors | Series D |
| M Ventures | Series D |
| RA Capital Management | Series D |
| Janus Henderson Investors | Series D |
| Avidity Partners | Series D |
| Invus | Series D |
Similar Companies
A snapshot of private companies similar to Artios Pharma Limited, helping you discover and navigate related company profiles.
Related News and Analysis
